Funder: Pfizer Inc.
Due Dates: March 30, 2026 (Submission deadline) | April 19, 2026 (Extended submission deadline)
Funding Amounts: Up to 2 million JPY per project; project duration up to 2 years (June 1, 2026 – May 31, 2028)
Summary: Supports quality improvement projects in Japan to enhance systems, collaboration, and expertise among healthcare professionals providing care to IBD patients.
Key Information: Only organizations in Japan are eligible; clinical research or drug efficacy studies are not supported.